12-Year outcome after normal myocardial perfusion SPECT in patients with known coronary artery disease
Journal of Nuclear Cardiology , Volume 20 - Issue 5 p. 748- 754
Background: Previous studies have reported a favorable outcome of patients with normal single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI). The aim of this study was to assess the very long-term prognosis of patients with known coronary artery disease (CAD) and normal SPECT MPI results. Methods: The population consisted of 266 patients with known CAD (defined as a healed myocardial infarction and/or a previous coronary revascularization), who underwent exercise bicycle or dobutamine-atropine stress SPECT MPI and had normal perfusion during stress and at rest. End points during follow-up were all-cause mortality, cardiac mortality, and nonfatal myocardial infarction. Univariate and multivariate analyses were performed to identify predictors of long-term outcome. Results: Follow-up was completed in 261 (98%) patients. During a median follow-up of 12 years, 94 (36%) patients died, of which 26 (10%) died due to cardiac causes, and 15 (6%) had a nonfatal myocardial infarction. The annualized mortality rate was 3.1%, annualized cardiac mortality rate was 0.9%, and the annualized event rate for cardiac death and/or nonfatal infarction was 1.2%. Independent predictors of total mortality were age, diabetes mellitus, and rate-pressure product at peak stress. Independent predictors of cardiac mortality were age, male gender, and rate-pressure product at peak stress. Conclusion: Patients with known CAD and a normal SPECT MPI study have a favorable long-term prognosis. Clinical and stress test variables can be used to identify patients with a higher risk status.
|Journal of Nuclear Cardiology|
|Organisation||Erasmus MC: University Medical Center Rotterdam|
Ottenhof, M, Wai, M.C.G.T.J, Boiten, H.J, Korbee, R.S, Valkema, R, van Domburg, R.T, & Schinkel, A.F.L. (2013). 12-Year outcome after normal myocardial perfusion SPECT in patients with known coronary artery disease. Journal of Nuclear Cardiology, 20(5), 748–754. doi:10.1007/s12350-013-9713-3